ausEE Inc.

ausEE Inc. is Australia’s national support and patient advocacy organisation for people affected by eosinophilic diseases. We extend our support to New Zealand.

We also support people who tube feed, and their families and carers, regardless of diagnosis. Founded in 2009, ausEE Inc. is an Australia wide health promotion charity, registered with the Australian Charities and Not-for-profits Commission and endorsed by the Australian Taxation Office as a deductible gift recipient. ausEE’s mission is to improve the lives of those affected by eosinophilic diseas

es through providing support, evidence-based information, resources, advocacy and by campaigning to raise awareness and funds for further research in Australia. Our objectives are:

• To improve the quality of life for people with eosinophilic diseases and other associated conditions.
• To help and support anyone diagnosed with or caring for someone with an eosinophilic disease and other associated conditions.
• To be a reliable and trusted source of information on eosinophilic diseases and other associated conditions.
• To develop, distribute and promote education, information and resources on eosinophilic diseases and other associated conditions.
• To create greater public awareness and understanding of eosinophilic diseases and other associated conditions and their impact.
• To engage in advocacy on behalf of people living with eosinophilic diseases and other associated conditions.
• To encourage, initiate, assist and support research into eosinophilic diseases and other associated conditions.
• To collaborate, partner and otherwise join with other persons or organisations, including research institutions and commercial entities in order to advance the objectives.
• To raise funds to enable the furtherance of these objectives. The content on our social media is not influenced by our supporters or sponsors and a link to a website or external contact does not imply that it is endorsed by ausEE Inc. The information we provide and share, and any related links is for general information and support purposes only and is not intended as a substitute for professional medical advice from your doctor or other health professional.

02/09/2026

We’re excited to be part of the 36th ASCIA (Australasian Society of Clinical Immunology and Allergy) Annual Conference, taking place this week at Te Pae Christchurch Convention Centre in New Zealand.

Sarah and Bella are representing ausEE and looking forward to connecting with allergy and immunology professionals, sharing information about eosinophil-associated diseases and our resources, and learning from the latest developments across the field.

We’re grateful to ASCIA for the opportunity to be part of this important conference and connect with delegates from across Australia and New Zealand.

Learn more about : https://ascia2026.com/

31/08/2026

Don’t miss your chance to be in TWO DRAWS with one $10 ticket!

Buy your Raffle 33 Play For Purpose ticket before 11:59pm AEST, 2 September and you’ll be entered into the Early Bird Bonus Draw for a chance to win a $10,000 Flight Centre voucher, plus go into the draw for the $350K First Prize Pack!

Every ticket also helps support ausEE’s work.

Don’t miss out. Get your ticket today!

🎟️ https://www.playforpurpose.com.au/ausEE

29/08/2026

This weekend, ausEE Inc. is exhibiting at the Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), held at the Perth Convention and Exhibition Centre.

Kristin and Sarah are excited to connect with delegates, share our patient resources on eosinophilic gastrointestinal diseases (EGIDs) and tube feeding, and hear from leading Australian and international experts in the field.

Learn more about : www.agw2026.org.au

25/08/2026

Researchers have identified a pathway that helps explain barrier dysfunction in eosinophilic esophagitis, providing support for current therapies and highlighting potential future treatment targets.

Read more on the Cincinnati Children’s science blog: https://scienceblog.cincinnatichildrens.org/study-links-inflammation-to-barrier-failure-in-eoe/

Read the journal publication: https://insight.jci.org/articles/view/204687

If this article raises questions for you, please discuss with your doctor.

20/08/2026

$13,540 raised for the Top 8 Challenge! 💜

We’re so grateful to everyone who has supported our campaign. Funds raised through the Top 8 Challenge help support research into eosinophil-associated diseases, helping to build a better understanding of these conditions and their impact on our community.

A special thank you to our anonymous donor for their generous $500 donation. We truly appreciate your support of research!

Support our campaign: https://top8challenge.com/donate

19/08/2026

Last chance to enter the August Bonus Draw! ⏰

Entries close tonight at 11:59pm AEST for your chance to win a $2,500 VISA voucher* in the Play For Purpose Bonus Draw!

Plus, every ticket goes into the draw for the $350K First Prize Pack, including a hybrid Lexus RX 450h+, $36K in shopping vouchers and $175K in gold bullion.

Your ticket also helps support ausEE’s work to provide information, resources, advocacy and support for people affected by eosinophil-associated diseases.

🎟️ Enter before 11:59pm AEST tonight, 19 August: https://www.playforpurpose.com.au/ausEE

18/08/2026

Consultation is open for the November 2026 Pharmaceutical Benefits Advisory Committee (PBAC) meeting and BUDESONIDE - Jorveza® oral suspension is on the agenda. This is a new oral suspension form of budesonide (BOS) for the treatment of patients with eosinophilic oesophagitis (EoE).

The PBAC welcomes input for their consideration when making their decision.

Please consider completing the online survey to share your personal journey living with EoE, or as a parent/carer of a child living with EoE, to let the PBAC know the impact living with EoE has on you and your family and what a difference it would make if Jorveza® oral suspension was listed on the Pharmaceutical Benefits Scheme (PBS).

Input can be submitted via the online survey, which can be accessed at: https://ohta-consultations.health.gov.au/ohta/pbac-november-2026/

For Question 7, please select ‘BUDESONIDE - Jorveza®: Eosinophilic oesophagitis’ from the medicine list.

The closing date for consumer comments is 16 September 2026.

For more information about this new PBS listing request please see page 23 of the PBAC meeting agenda: https://www.pbs.gov.au/industry/listing/elements/pbac-meetings/agenda/november-2026-pbac-meeting

17/08/2026

Supporter Spotlight: Kathleen from Milly’s Girl 💜

On Top 8 Challenge Day, 8 August, Kathleen from Milly’s Girl held a special fundraiser at The Nest Markets. Kathleen creates beautiful handmade jewellery and made some special pieces in our eosinophil-associated disease awareness colours of pink and purple, with sales from the fundraiser donated to ausEE Inc.

This cause is especially close to Kathleen’s heart, with both of her sons living with eosinophilic oesophagitis. We’re incredibly grateful to Kathleen for turning her passion for handmade jewellery into an opportunity to raise awareness and funds for research.

Thank you, Kathleen, for taking on our Top 8 Challenge and making the day extra special! 💜

Address

PO Box 9923, Frenchville
Rockhampton, QLD
4701

Telephone

+611300923043

Website

https://www.ausee.org/

Alerts

Be the first to know and let us send you an email when ausEE Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ausEE Inc.:

Want your business to be the top-listed Health & Beauty Business in Rockhampton?